# Coya Therapeutics, Inc.: Form 8-K, filed Apr 2, 2026

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 8-K
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 08:48 ET
- Period: 2026-03-29
- Accession: 0001193125-26-139094
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000119312526139094/d104763d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000119312526139094/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000119312526139094/d104763d8k.htm

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-139094. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
